PILA PHARMA

1.45 SEK

-1.02 %

Less than 1K followers

PILA

First North Stockholm

Biotechnology & Pharmaceuticals

Health Care

-1.02 %
-4.48 %
+9.02 %
-29.61 %
-34.98 %
-50.74 %
-41.94 %
-
-81.44 %

PILA PHARMA is a clinical stage biotechnology company based in Malmö, Sweden. The company is developing novel oral therapeutics for globally common metabolic diseases such as Diabetes, Obesity and Cardiovascular diseases as well as therapeutics for Pain treatment. The company has obtained an orphan drug designation in the United States for the painful rare disease Erythromelalgia. The company is specializing in development of pharmaceutical drugs based on TRPV1-antagonists.

Read more
Market cap
66.24M SEK
Turnover
21.92K SEK
Revenue
1.13M
EBIT %
-698.23 %
P/E
-
Dividend yield-%
-
Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
19/5
2026

General meeting '26

27/8
2026

Interim report Q2'26

25/2
2027

Annual report '26

ShowingAll content types

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.